Artificial Intelligence Predicts Next Session’s Price Change For Kinder Morgan, Moderna, Honda

(VIANEWS) – Today, the Innrs artificial intelligence algorithm suggests a high probability of discovering the approximate price for tomorrow of Kinder Morgan KMI, Moderna MRNA and others.

Via News will regularly fact-check this AI algorithm that aims to consistently predict the next session price and next week’s trend of financial assets.

Innrs provides A.I.-based statistical tools to help investors make decisions. The table below shows the financial assets predicting price, ordered by the highest expected accuracy.

Innrs officials say this tool helps investors make better-informed decisions, supposedly used alongside other relevant financial information and the specific trader strategy.

In the next session, Via News will report the finding on the algorithm precision.

Financial Asset Accuracy Close Price Prediction
Kinder Morgan (KMI) 94.28% $17.11 $16.97
Moderna (MRNA) 92.06% $139.17 $137.27
Honda (HMC) 89.5% $26 $26.37
Coinbase (COIN) 88.4% $64.96 $62.57
Aware, Inc. (AWRE) 87.91% $1.61 $1.52
Church & Dwight Company (CHD) 87.69% $83.83 $86.39
Arcturus Therapeutics (ARCT) 85.84% $16.17 $14.77
PT Telekomunikasi (TLK) 84.26% $25.69 $26.27
Orix Corp (IX) 84.18% $89.46 $90.01
Vodafone (VOD) 83.93% $12.02 $12.06
BioNTech SE (BNTX) 83.77% $130.01 $125.3
Cliffs Natural Resources (CLF) 83.47% $21.32 $21.61
Colgate-Palmolive (CL) 83.44% $73.49 $75.46

1. Kinder Morgan (KMI)

Shares of Kinder Morgan slid 5.73% in from $18.15 to $17.11 at 18:21 EST on Tuesday, after two sequential sessions in a row of losses. NYSE is falling 0.41% to $15,428.97, after two consecutive sessions in a row of losses.

Kinder Morgan, Inc. operates as an energy infrastructure company in North America. The company operates through four segments: Natural Gas Pipelines, Products Pipelines, Terminals, and CO2. The Natural Gas Pipelines segment owns and operates interstate and intrastate natural gas pipeline, and underground storage systems; natural gas gathering systems and natural gas processing and treating facilities; natural gas liquids fractionation facilities and transportation systems; and liquefied natural gas gasification, liquefaction, and storage facilities. The Products Pipelines segment owns and operates refined petroleum products, and crude oil and condensate pipelines; and associated product terminals and petroleum pipeline transmix facilities. The Terminals segment owns and/or operates liquids and bulk terminals that stores and handles various commodities, including gasoline, diesel fuel, renewable fuel stock, chemicals, ethanol, metals, and petroleum coke; and owns tankers. The CO2 segment produces, transports, and markets CO2 to recovery and production crude oil from mature oil fields; owns interests in/or operates oil fields and gasoline processing plants; and operates a crude oil pipeline system in West Texas, as well as owns and operates RNG and LNG facilities. It owns and operates approximately 83,000 miles of pipelines and 140 terminals. The company was formerly known as Kinder Morgan Holdco LLC and changed its name to Kinder Morgan, Inc. in February 2011. Kinder Morgan, Inc. was founded in 1936 and is headquartered in Houston, Texas.

Moving Average

Kinder Morgan’s value is below its 50-day moving average of $18.21 and below its 200-day moving average of $18.07.

More news about Kinder Morgan.

2. Moderna (MRNA)

Shares of Moderna slid by a staggering 30.65% in from $200.68 to $139.17 at 18:21 EST on Tuesday, after five sequential sessions in a row of losses. NASDAQ is sliding 0.1% to $11,455.54, after two sequential sessions in a row of losses.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Revenue Growth

Year-on-year quarterly revenue growth declined by 32.3%, now sitting on 21.39B for the twelve trailing months.

Sales Growth

Moderna’s sales growth is negative 30.4% for the ongoing quarter and negative 74.8% for the next.

More news about Moderna.

3. Honda (HMC)

Shares of Honda jumped 6.91% in from $24.32 to $26.00 at 18:21 EST on Tuesday, following the last session’s upward trend. NYSE is sliding 0.41% to $15,428.97, after two successive sessions in a row of losses.

Honda Motor Co., Ltd. develops, manufactures, and distributes motorcycles, automobiles, power products, and other products in Japan, North America, Europe, Asia, and internationally. It operates through four segments: Motorcycle Business, Automobile Business, Financial Services Business, and Life Creation and Other Businesses. The Motorcycle Business segment produces motorcycles, including sports, business, and commuter models; and various off-road vehicles, such as all-terrain vehicles and side-by-sides. The Automobile Business segment offers passenger cars, light trucks, and mini vehicles. The Financial Services Business segment provides various financial services, including retail lending and leasing services to customers, as well as wholesale financing services to dealers. The Life Creation and Other Businesses segment manufactures and sells power products, such as general purpose engines, generators, water pumps, lawn mowers, riding mowers, robotic mowers, brush cutters, tillers, snow blowers, outboard marine engines, walking assist devices, and portable battery inverter power sources. This segment also offers HondaJet aircraft. The company also sells spare parts; and provides after-sale services through retail dealers directly, as well as through independent distributors and licensees. Honda Motor Co., Ltd. was founded in 1946 and is headquartered in Tokyo, Japan.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Honda’s stock is considered to be overbought (>=80).

More news about Honda.

4. Coinbase (COIN)

Shares of Coinbase rose by a staggering 15.63% in from $56.18 to $64.96 at 18:21 EST on Tuesday, after four sequential sessions in a row of losses. NASDAQ is dropping 0.1% to $11,455.54, after two consecutive sessions in a row of losses.

Coinbase Global, Inc. provides financial infrastructure and technology for the cryptoeconomy in the United States and internationally. The company offers the primary financial account in the cryptoeconomy for retailers; a marketplace with a pool of liquidity for transacting in crypto assets for institutions; and technology and services that enable ecosystem partners to build crypto-based applications and securely accept crypto assets as payment. Coinbase Global, Inc. was founded in 2012 and is based in Wilmington, Delaware.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Coinbase’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth grew by 327.1%, now sitting on 7.84B for the twelve trailing months.

More news about Coinbase.

5. Aware, Inc. (AWRE)

Shares of Aware, Inc. dropped 4.35% in from $1.68 to $1.61 at 18:21 EST on Tuesday, after five sequential sessions in a row of losses. NASDAQ is sliding 0.1% to $11,455.54, after two successive sessions in a row of losses.

Aware, Inc. provides biometrics software products and solutions in the United States, Brazil, the United Kingdom, and internationally. It offers biometrics software products, including biometric search and matching software development kits (SDKs); biometric enrollment SDKs and application programming interfaces (APIs); and imaging products for medical and advanced imaging applications, such as JPEG2000 product to compress, store, and display images, as well as software maintenance services. The company also provides Knomi mobile biometric authentication framework; AwareABIS, an automated biometric identification system; AFIX suite of products for small-scale law enforcement focused biometric identification; BioSP, a biometric services platform; WebEnroll, a browser-based biometric enrollment and data management solution; AwareID, a software-as-a-service that provides biometric face and voice analysis for liveness-verification, and document validation; and Fortress Identity Biometric Authenticator and Onboarding Authentication Platform, which offers multi-factor authentication through passive and active biometrics for multiple modalities, including voice, fingerprint, face, and behavior to enable online onboarding and identity proofing. In addition, it offers program management and software engineering services, including project planning and management; system and architecture design; software design, development, customization, configuration, and testing; and software integration and installation. The company's software portfolio enables government agencies and commercial entities to enroll, identify, authenticate, and enable using biometrics, such as fingerprints, faces, irises, and voices. The company sells its products through systems integrators, original equipment manufacturers, value added resellers, and partners, as well as directly to end user customers. Aware, Inc. was incorporated in 1986 and is headquartered in Burlington, Massachusetts.

Volatility

Aware, Inc.’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.56%, a negative 1.11%, and a positive 2.94%.

Aware, Inc.’s highest amplitude of average volatility was 3.56% (last week), 2.84% (last month), and 2.94% (last quarter).

Yearly Top and Bottom Value

Aware, Inc.’s stock is valued at $1.61 at 18:21 EST, way under its 52-week high of $3.57 and way above its 52-week low of $1.32.

More news about Aware, Inc..

6. Church & Dwight Company (CHD)

Shares of Church & Dwight Company jumped 3.89% in from $80.69 to $83.83 at 18:21 EST on Tuesday, after five consecutive sessions in a row of losses. NYSE is sliding 0.41% to $15,428.97, after two successive sessions in a row of losses.

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Revenue Growth

Year-on-year quarterly revenue growth grew by 4.9%, now sitting on 5.38B for the twelve trailing months.

More news about Church & Dwight Company.

7. Arcturus Therapeutics (ARCT)

Shares of Arcturus Therapeutics slid by a staggering 25.73% in from $21.77 to $16.17 at 18:21 EST on Tuesday, after three sequential sessions in a row of losses. NASDAQ is dropping 0.1% to $11,455.54, after two consecutive sessions in a row of losses.

Arcturus Therapeutics Holdings Inc. operates as a late-stage clinical mRNA medicines and vaccines company. Its technologies include LUNAR lipid-mediated delivery; STARR mRNA Technology (samRNA); and mRNA drug substance. The company's pipeline of RNA therapeutic and vaccine candidates includes mRNA vaccine programs for SARS-CoV-2 (COVID-19) and Influenza, and other programs to treat ornithine transcarbamylase (OTC) deficiency, and cystic fibrosis with partnered programs, including glycogen storage disease type III and hepatitis B virus. Its RNA therapeutics platforms can be applied in multiple types of nucleic acid medicines, including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics. Its technologies are covered by its patent portfolio, including patents and patent applications issued in the U.S., Europe, Japan, China, and other countries. The company was founded in 2013 and is headquartered in San Diego, California.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Arcturus Therapeutics’s stock is considered to be overbought (>=80).

Volatility

Arcturus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.12%, a negative 1.27%, and a positive 3.28%.

Arcturus Therapeutics’s highest amplitude of average volatility was 2.44% (last week), 2.95% (last month), and 3.28% (last quarter).

Moving Average

Arcturus Therapeutics’s worth is way under its 50-day moving average of $18.65 and below its 200-day moving average of $17.35.

More news about Arcturus Therapeutics.

8. PT Telekomunikasi (TLK)

Shares of PT Telekomunikasi dropped 3.11% in from $26.51 to $25.69 at 18:21 EST on Tuesday, after two sequential sessions in a row of losses. NYSE is dropping 0.41% to $15,428.97, after two successive sessions in a row of losses.

Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk provides telecommunications, informatics, and network services worldwide. The company's Mobile segment offers mobile voice, SMS, and mobile broadband services; and digital services, including financial services, video on demand, music, gaming, IoT, big data analytics, and digital advertising services. Its Consumer segment provides fixed voice and broadband services; and IPTV and related consumer digital services. The company's Enterprise segment offers ICT and digital platform that covers enterprise-grade connectivity services, including satellite, IT services, data center and cloud, and business process outsourcing services, as well as CPE trading and managed, cyber security, financial, big data, digital advertising, e-health, managed ATM, and professional services. Its Wholesale and International Business segment provides wholesale voice, managed, A2P SMS, IP transit and connectivity, data center and cloud, security, and value added and digital services; mobile network operator, mobile virtual network operator, and call center services; and tower and infrastructure services to other licensed operator companies and institutions. The company's Others segment offers digital services, such as digital platform, digital content, and e-commerce; and property management services. The company also provides building management and maintenance services, payment, business management consulting and capital venture, health insurance administration, tourism, directory information, telecommunication construction, and multimedia portal services; acts as a civil consultant and developer; and leases offices. As of December 31, 2020, it had approximately 9.1 million fixed wireline subscribers, including 8.0 million fixed broadband subscribers; and 169.5 million cellular subscribers, including 115.9 million mobile broadband subscribers. The company was founded in 1884 and is headquartered in Bandung, Indonesia.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PT Telekomunikasi’s stock is considered to be oversold (<=20).

More news about PT Telekomunikasi.

9. Orix Corp (IX)

Shares of Orix Corp jumped 2.7% in from $87.11 to $89.46 at 18:21 EST on Tuesday, after two sequential sessions in a row of gains. NYSE is falling 0.41% to $15,428.97, after two successive sessions in a row of losses.

ORIX Corporation provides diversified financial services in Japan, the Americas, Asia, Europe, Australasia, the Middle East, and internationally. The company's Corporate Financial Services and Maintenance Leasing segment is involved in the finance and fee; leasing and rental of automobiles, electronic measuring instruments, and ICT-related equipment businesses; and provision of life insurance and environment and energy-related products and services. Its Real Estate segment develops, rents, and manages real estate properties; operates facilities; manages residential condominiums and office building; and provides construction contracting, real estate brokerage, and real estate investment advisory services. The company's PE Investment and Concession segment engages in the private equity (PE) investment and concession businesses. Its Environment and Energy segment provides renewable energy; ESCO; retails electric power; sells solar panels and battery electricity storage systems; and recycling and waste management services. The company's Insurance segment sells life insurance products through agents, banks, and other financial institutions, as well as face-to-face and online. Its Banking and Credit segment provides banking and consumer finance services. The company's Aircraft and Ships segment engages in the aircraft leasing and management, and ship-related finance and investment businesses. Its ORIX USA segment offers finance, investment, and asset management services. The company's ORIX Europe segment provides equity and fixed income asset management services. Its Asia and Australia segment offers finance and investment businesses. The company was formerly known as Orient Leasing Co., Ltd. and changed its name to ORIX Corporation in 1989. ORIX Corporation was incorporated in 1950 and is headquartered in Tokyo, Japan.

More news about Orix Corp.

10. Vodafone (VOD)

Shares of Vodafone rose 3.44% in from $11.62 to $12.02 at 18:21 EST on Tuesday, following the last session’s upward trend. NASDAQ is dropping 0.1% to $11,455.54, after two consecutive sessions in a row of losses.

Vodafone Group Public Limited Company engages in telecommunication services in Europe and internationally. The company offers mobile services that enable customers to call, text, and access data; fixed line services, including broadband, television (TV) offerings, and voice; and convergence services under the GigaKombi and Vodafone One names to customers. It also provides value added services, such as Internet of Things (IoT) comprising logistics and fleet management, smart metering, insurance, cloud, and security services; and automotive and health solutions. In addition, the company offers M-Pesa, an African payment platform, which provides money transfer, financial, and business and merchant payment services; and various services to operators through its partner market agreements. Vodafone Group Public Limited Company has a strategic partnership with Open Fiber. As of March 31, 2022, it had approximately 323 million mobile customers, 28 million fixed broadband customers, and 22 million TV customers. The company was incorporated in 1984 and is based in Newbury, the United Kingdom.

Moving Average

Vodafone’s worth is above its 50-day moving average of $11.07 and under its 200-day moving average of $12.92.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Vodafone’s stock is considered to be oversold (<=20).

Volatility

Vodafone’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.99%, a positive 0.11%, and a positive 1.44%.

Vodafone’s highest amplitude of average volatility was 1.75% (last week), 1.77% (last month), and 1.44% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 2%, now sitting on 46.02B for the twelve trailing months.

More news about Vodafone.

11. BioNTech SE (BNTX)

Shares of BioNTech SE dropped 7.97% in from $141.27 to $130.01 at 18:21 EST on Tuesday, after five successive sessions in a row of losses. NASDAQ is sliding 0.1% to $11,455.54, after two consecutive sessions in a row of losses.

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, a preclinical stage product for non-small cell lung cancer. It also develops neoantigen specific immunotherapies, such as Autogene cevumeran (BNT122), which is in Phase II clinical trial for first-line melanoma, as well as in Phase 1a/1b clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT153 to treat solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT221 for other cancers; and checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I/II clinical trial to treat solid tumors. Further, it develops BNT321, an IgG1 monoclonal antibody in Phase II clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate for solid tumors; prophylactic vaccine for COVID-19 and Influenza; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; Regeneron Pharmaceuticals, Inc. and Ryvu Therapeutics S.A. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

Yearly Top and Bottom Value

BioNTech SE’s stock is valued at $130.01 at 18:21 EST, way under its 52-week high of $189.07 and way higher than its 52-week low of $117.08.

More news about BioNTech SE.

12. Cliffs Natural Resources (CLF)

Shares of Cliffs Natural Resources jumped 0.28% in from $21.26 to $21.32 at 18:21 EST on Tuesday, following the last session’s upward trend. NYSE is falling 0.41% to $15,428.97, after two sequential sessions in a row of losses.

Cleveland-Cliffs Inc. operates as a flat-rolled steel producer in North America. The company offers carbon steel products, such as hot-rolled, cold-rolled, electrogalvanized, hot-dip galvanized, hot-dip galvannealed, aluminized, enameling, and advanced high-strength steel products; stainless steel products; plates; and grain oriented and non-oriented electrical steel products. It also provides tubular components, including carbon steel, stainless steel, and electric resistance welded tubing. In addition, the company offers tinplate products, such as electrolytic tin coated and chrome coated sheet, and tin mill products; tooling and sampling; raw materials; ingots, rolled blooms, and cast blooms; and hot-briquetted iron products. Further, it owns five iron ore mines in Minnesota and Michigan. The company serves automotive, infrastructure and manufacturing, distributors and converters, and steel producers. Cleveland-Cliffs Inc. was formerly known as Cliffs Natural Resources Inc. and changed its name to Cleveland-Cliffs Inc. in August 2017. The company was founded in 1847 and is headquartered in Cleveland, Ohio.

Volatility

Cliffs Natural Resources’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.45%, a negative 0.35%, and a positive 2.42%.

Cliffs Natural Resources’s highest amplitude of average volatility was 1.49% (last week), 1.43% (last month), and 2.42% (last quarter).

More news about Cliffs Natural Resources.

13. Colgate-Palmolive (CL)

Shares of Colgate-Palmolive jumped 0.88% in from $72.85 to $73.49 at 18:21 EST on Tuesday, after five sequential sessions in a row of losses. NYSE is falling 0.41% to $15,428.97, after two sequential sessions in a row of losses.

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

More news about Colgate-Palmolive.

Leave a Reply

Your email address will not be published. Required fields are marked *